A New Hope in Cancer Treatment: Zymeworks' Promising Early Results
Zymeworks, a biotech company, has shared positive early results from its phase 1 trial. The trial is for a new drug called ZW-191. This drug is designed to target a specific marker called folate receptor-alpha (FRα) found in many cancer types. The results show that ZW-191 can shrink tumors and is ge